ESMO 2022: Update of the lenvatinib plus pembrolizumab versus sunitinib study in patients with advanced kidney cancer
Results from the phase 3 CLEAR studywere presented at the [...]
Results from the phase 3 CLEAR studywere presented at the [...]
The results from the IMmotion010 study were presented at the [...]
In this phase 3 randomised study, presented at the European [...]
The results of COSMIC-131 were presented at the European Society [...]
Neutrophils and eosinophils are white blood cells. In this study, [...]
Neoadjuvant treatment is medication that is given before surgery to [...]
This review summarises the outcomes of people with COVID-19 taking [...]
MiT family translocation renal cell carcinoma is a rare and [...]
This recent study looked at the effects of cabozantinib on [...]
Many patients with low-risk or favourable-risk kidney cancer may have [...]